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Abstract
Background: It is well known that CD1d-restricted Va14 invariant natural killer T (NKT) cells are derived from cells in the
CD4
+CD8
+ double-positive (DP) population in the thymus. However, the developmental progression of NKT cells in the
earlier stages remains unclear, and the possible existence of NKT cell presursors in the earlier stages than DP stage remains
to be tested.
Principal Findings: Here, we demonstrate that NKT cell precursors that express invariant Va14-Ja18 transcripts but devoid of
surface expression of the invariant Va14 receptor are present in the late CD4
2CD8
2 double-negative (DN)4 stage and have
the potential to generate mature NKT cells in both in vivo and in vitro experimental conditions. Moreover, the DN4
population in CD1d knock-out (CD1dKO) mice was similar to those with an NKT cell potential in wild-type (WT) C57BL/6 (B6)
mice, but failed to develop into NKT cells in vitro. However, these precursors could develop into NKT cells when co-cultured
with normal thymocytes or in an in vivo experimental setting, indicating that functional NKT cell precursors are present in
CD1dKO mice.
Conclusions: Together, these results demonstrate that thymic DN4 fraction contains NKT cell precursors. Our findings
provide new insights into the early development of NKT cells prior to surface expression of the invariant Va14 antigen
receptor and suggest the possible alternative developmental pathway of NKT cells.
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Introduction
The developmental progression of the T cell lineage in the thymus
is precisely controlled, beginning with the early T cell precursors,




double-negative (DN) thymocytes. The DN population in the thymus








2)a n dD N 4( C D 2 5
2 CD44
2), which are sequential
developmental stages [1]. Major commitment events to the ab T
cell lineage occur at the DN3 stage, where rearrangement of the T
cellreceptor (TCR) b chain gene (Tcrb) and subsequent beta-selection
for a functional TCRb chain take place. The cells that survive beta-
selection develop into the DN4 stage to become CD4
+CD8
+ double-
positive (DP) thymocytes. In the case of conventional ab T cells,
rearrangement of the TCRa chain gene locus occurs at the DP stage,
and those cells that make productive rearrangements undergo MHC-
mediated positive and negative selection to generate single-positive
(SP) CD4 or CD8 T cells [2].
Natural killer T (NKT) cells are characterized by the expression
of an invariant antigen receptor encoded by Va14-Ja18 in mice
and Va24-Ja18 in humans. This receptor is used preferentially by
NKT cells but not by conventional T cells, defining NKT cells as a
distinct lineage from conventional T cells [3]. NKT cells recognize
self- or non-self glycolipid ligands in conjunction with the
monomorphic MHC-like molecule CD1d [4], and mediate
intermediary functions that link the innate and acquired immune
systems, regulating protective and regulatory responses by their
rapid secretion of large amounts of cytokines such as IL-4, and
IFN-c after activation [5,6].
Since the discovery of this unique cell lineage, the develop-
mental pathway of NKT cells has been one of the most intriguing
topics. Based on previous findings that cells with NKT cell
potential can be detected in the DP thymocyte population [7,8],
NKT cells have been thought to branch off from conventional ab
T cell precursors at the DP stage in the thymus, where the cells in
the DP thymocyte pool expressing a rearranged invariant Va14-
Ja18 TCR are positively selected by CD1d
+ thymocytes [6–10].
However, currently available data do not rule out the possibility
that NKT cells are derived from a precursor population distinct
from that of conventional ab T cells. Findings in support of
independent origins for conventional T and NKT cells include the
detection of invariant Va14-Ja18 transcripts before thymus
formation in fetal (RAG-1-KO6WT)F1 mice, in which the
possibility of contamination with maternal NKT cells in the
samples tested is formally excluded [11], and the cell surface
expression by NKT precursor cells and NKT cells of the
granulocyte-macrophage colony stimulating factor (GM-CSF)
receptor [12,13], which is a unique marker for myeloid but not
lymphoid lineage cells. Considering their unique characteristics
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NKT cell precursors might differ from those of conventional T
cells and exist at earlier stages than the DP stage previously defined
by fate-mapping studies [8]. To test this possibility, we focused on
cells with NKT cell potential at early stages of development, prior
to the DP stage in the thymus.
In the present study, we demonstrate that NKT cell precursors
are present in DN4 stage thymocytes and have the potential to
give rise to mature NKT cells in both in vivo and in vitro
experimental settings. Our findings provide new insights into the
early development of NKT cells before expression of the invariant
Va14-Ja18 antigen receptor.
Results and Discussion
Invariant Va14-Ja18 transcripts are present in the thymic
DN4 fraction
ToinvestigatewhethertheDNpopulation inthe thymuscontains
cells with NKT cell potential, we first purified Lin
2 DN3 and DN4
thymocyte fractions devoid of Lin marker positive mature cells,
including NKT cells, by a three-step cell purification method. In the
first step, the DN fraction was enriched by depletion of DP and SP
thymocytes by magnetic-activated cell sorting (MACS) using
microbeads coated with anti-CD4 and anti-CD8 monoclonal
antibodies (mAbs). Then the DN enriched fraction was stained
with a biotin-labeled Lin mAb ‘cocktail’ (anti-B220, CD3e, CD11b,
CD11c, CD19, Gr-1, TER-119, TCRb,T C R cd) and subsequently
reacted with streptavidin microbeads to deplete Lin
+ cells using
MACS columns. The resulting Lin
2 cells in the eluate fraction were
sorted by staining with fluorescent-conjugated streptavidin and also
with directly labeled mAbs (anti-CD4, CD8a,T C R b,T C R cd,
NK1.1) together with a-galactosylceramide-loaded CD1d (aGC/
CD1d) dimer which specifically detects NKT cells [14] to remove
any unstained NKT cells and Lin
+ cells left in the samples. This
rigorous cell preparation method and staining protocol was used
throughout this study unless otherwise indicated. The Lin
2 aGC/
CD1d dimer
2 DN fraction was further analyzed by the CD25,
CD44 bivariate staining pattern, which defines the well-character-
ized thymocyte differentiation pathway. As shown in Figure 1A
(upper panel), the DN fraction of B6 mice contain neither DP or SP
thymocytes, nor aGC/CD1d dimer
+ NKT cells or Lin
+ cells. When
highly purified DN3 and DN4 fractions from C57BL/6 (B6) mice
were analyzed by RT-PCR, the bands corresponding to NKT cell-
specific Va14-Ja18 sequences were detected in the DN4 but not
DN3 fraction (Figure 1B).
Becausea fractionofNKTcellsinthethymusis DNandCD44
2,
it is still possible that the DN fraction isolated by this method may
contain mature or immature NKT cells. To exclude this possibility,
we isolated the DN4 fraction from the thymus of CD1d knock-out
(CD1dKO) mice, in which NKT cells do not exist because of the
lack of expression of CD1d as a selection molecule [15–17]. The
fluorescence-activated cell sorter (FACS) profiles of the CD1dKO
DN fractions were essentially identical to those obtained from B6
mice (Figure 1A, lower panel). Notably, results from the RT-PCR
analysis of the CD1dKO DN fractions were identical to those from
B6 mice, where the DN4 but not DN3 fraction in both mice
expressed NKT cell-specific Va14-Ja18 transcripts (Figure 1C). The
identitiesof the Va14-Ja18 transcripts detected in the DN4 fractions
of B6 and CD1dKO mice were confirmed by direct sequencing of
the PCR products (data not shown).
In addition to their expression of invariant Va14-Ja18
transcripts, the DN4 fraction of B6 and CD1dKO mice contained
TCRb chain transcripts (Figures 1B and 1C), suggesting that both
invariant Va14-Ja18 and TCRb transcripts are already present in
the DN4 stage before the cells reach the DP stage. It is important
to note that our present findings do not necessarily contradict the
previous report, demonstrating that the invariant Va14-Ja18
transcripts are detectable at the DP stage [7].
Regarding the possibility of early invariant Va14-Ja18 gene
rearrangement in the DN population, it has recently been shown
that low level of TCRa chain gene rearrangement in the late DN
stage, which was previously considered to represent a transgenic
artifact, occurs even under physiological conditions [18]. The
present findings support the possibility that the DN4 fraction in the
thymus contains precursors for the NKT cell lineage.
Gene expression profile and surface phenotype of the
DN4 thymic fraction
To further characterize the DN4 population in the thymus, we
used RT-PCR to investigate the expression of genes relevant to the
NKT cell development. As shown in Figures 1B and 1C, both B6
and CD1dKO DN4 cells, as well as DN3 cells used as positive
controls, expressed transcripts encoding RAG-1/RAG-2, which are
required for the rearrangement of TCR gene segments. They also
expressed transcripts for pTa (Ptcra), which is required for the NKT
cell development in a cell autonomous manner [19]. The thymus-
specific isoform of retinoic acid receptor-related orphan receptor c
(RORct) appears to be required for the rearrangement of the Va14-
Ja18 gene segments as it was shown that RORct-deficient mice lack
Va14-Ja18 transcripts and consequently are deficient in NKT cells
[8,10]. As shown in Figures 1B and 1C, RORct transcripts were
clearly detected in the DN4 fraction, and to a lesser extent in the
DN3 fraction in both B6 and CD1dKO mice.
Considering that DP thymocytes exclusively express RORct
and using the RORct-Cre fate-mapping method, it has been
concluded that all NKT cells and ab T cells are derived from DP
thymocyte precursors [8]. Our data (Figures 1B and 1C) and those
of others [20,21] clearly demonstrate that RORct expression
begins at the DN3 stage, presumably as a result of pre-TCR
signaling. Moreover, the recent report that not all ab T cells
develop through the DP stage [18] supports the possibility that
some of NKT cells are not derived from DP precursors.
Next, we analyzed the surface phenotype of the DN4 thymic
fraction from both B6 and CD1dKO mice. In contrast to aGC/
CD1d dimer





+, both B6 and CD1dKO aGC/
CD1d dimer





2 (Figure S1). Thus, the DN4
population is different from the aGC/CD1d dimer
+ NKT cells in
terms of cell surface phenotype.
It is well established that the earliest detectable NKT cell
precursors just after positive-selection with CD1d in the thymus,








+ surface phenotype [22]. Given our
findings that the DN4 fraction lacked expression of the cell surface
invariant Va14 receptor (Figure 1A) and CD69 (Figure S1), but
possessed the NKT cell-specific Va14-Ja18 transcripts in
CD1dKO mice (Figure 1C), we considered that the DN4
population contains the bona fide precursors to NKT cells prior
to positive-selection with CD1d in the thymus.
In vitro generation of NKT cells from the DN4 fraction
To determine whether the DN4 fraction, which expresses Va14-
Ja18 transcripts but no cell surface TCR, has NKT cell precursor
potential, we co-cultured the DN4 population with OP9 stromal
cells engineered to express Notch ligand delta-like 1 (OP9/Dll-1)
that support conventional T cell differentiation in vitro [23].
Although the developmental requirements of NKT cells might
Thymic NKT Cell Precursor
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monolayer culture system was chosen because of its ability to
promote the survival of immature T cells [24].
Highly purified ($99%) DN4 cells from either B6 or CD1dKO
mice (Figures 1A and S2) were co-cultured with OP9/Dll-1 in the
presence of IL-2, IL-7, and IL-15, as these cytokines are known to
have an important role in NKT cell homeostasis [25]. After 8 to 10
days of culture, the DN4 cells from B6 mice, but not those from
CD1dKO mice, successfully generated aGC/CD1d dimer
+ NKT
cells (Figure 2A).
To formally exclude the possibility of contamination of our
culture system with mature NKT cells and to confirm the
presence of NKT cell precursors in the DN4 fraction of
CD1dKO mice, we mixed the DN4 fraction from B6.CD45.1
congenic mice with the DN4 fraction from CD1dKO mice at 7:3
ratio, and then co-cultured with OP9/Dll-1. The CD1dKO DN4
cells, identified as CD45.2
+, were able to generate aGC/CD1d
dimer
+ NKT cells in the presence of WT CD1d
+/CD45.1
+
thymocytes in the 8 day-culture (Figure 2B). These results,
together with the data shown in Figure 1C, clearly demonstrated
the presence of NKT precursors in the DN4 population. In
addition, the results shown in Figure 2B confirmed the
requirement for CD1d-expressing thymocytes for the develop-
ment of NKT cells, in agreement with previous reports [9].
Figure 1. Isolation of the DN4 thymocytes and gene expression analysis. (A) FACS profiles of CD25, CD44 staining of DN thymocytes from
B6 and CD1dKO mice. The numbers in FACS plots represent the percentage of cells in the indicated quadrants. DN thymocytes from B6 and CD1dKO
mice were enriched by MACS depletion of DP, SP and mature Lin
+ cell types. aGC/CD1d dimer was used to exclude NKT cells from the DN thymocytes
and an extensive lineage mAb ‘cocktail’ (anti-B220, CD3e, CD11b, CD11c, CD19, Gr-1, TER-119, TCRb, TCRcd) was used to remove mature cell types.
Dot plots were obtained on a 6-color FACS Aria and are representative of more than six independent experiments for each group of mice. (B and C)
Gene expression profiles of the DN3 and DN4 thymic fractions. All mRNA samples of B6 and CD1dKO mice were normalized to the Hprt expression
level and analyzed by RT-PCR. Horizontal wedges indicate three-fold serial dilutions of cDNA samples. Total thymocytes from B6 mice were used as
positive controls. Data are representative RT-PCR results of four independent experiments for each group of mice.
doi:10.1371/journal.pone.0003688.g001
Thymic NKT Cell Precursor
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generated in vitro from DN4 thymic fraction
FACS analysis shown in Figure 3A revealed that the most
aGC/CD1d dimer
+ NKT cells generated in vitro from the B6 DN4
population were of the NK1.1
2, DN, and CD44
+ phenotype,




+ phenotype. A standard cytokine secretion assay
using a-galactosylceramide (aGalCer)-pulsed GM-CSF-induced
bone marrow-derived dendritic cells (GM-DC) demonstrated that
the in vitro derived NKT cells secreted both IFN-c and IL-4 in a
CD1d-dependent manner, which is the hallmark of NKT cells
(Figure 3B). Of note, the cytokine secretion profiles of the in vitro
generated NKT cells were more of Th1-type, with very little IL-4,
compared with their ex vivo counterparts (Figure 3B). These
differences between in vitro generated NKT cells and ex vivo thymic
NKT cells may be due to the limits of the OP9/Dll-1 culture
system, which has been reported to support the preferential
development of IFN-c producing CD8 T cells [23], and may also
indicate a requirement for the intact thymic microenvironment for
the full differentiation of NKT cells [26]. It was also reported that
human DN NKT cells show Th1-type biased cytokine response
upon stimulation [27]. Collectively, the data shown in Figures 3A
and 3B suggest that the in vitro generated NKT cells resemble those
found in vivo.
In vivo generation of NKT cells from DN4 thymocytes
To further substantiate and confirm our findings in Figure 2B,
showing that CD1dKO DN4 population contains cells with NKT
cell potential, highly purified DN4 cells from CD1dKO (CD45.2
+)
mice were injected intrathymically into B6.CD45.1-congenic
recipients.
As demonstrated in Figure 4A, transfer of CD45.2
+ CD1dKO-
derived DN4 donor cells successfully generated aGC/CD1d
dimer
+ NKT cells in the WT CD45.1 recipient thymus. The
surface phenotype of these in vivo generated aGC/CD1d dimer
+
NKT cells from CD1dKO donors resembled that of resident NKT
cells in the WT recipients, where the majority of NKT cells were
NK1.1
+ and CD44
+ (Figure 4B). These results demonstrated that
the DN4 thymocytes from CD1dKO mice contained precursors of
NKT cells, which is consistent with the presence of the invariant
Va14-Ja18 transcripts in this population (Figure 1C), and the
potential of these cells to give rise to NKT cells when cultured in
vitro (Figure 2B).
Taken together, we have identified cells in the thymic DN4
population with NKT cell potential in both in vitro and in vivo
experimental settings. Studies to elucidate the differentiation
pathway(s) of NKT cells should provide further insights into
NKT cell biology and provide clues to solve the puzzles
concerning developmental requirements of this unique cell lineage.
Figure 2. In vitro generation of aGC/CD1d dimer
+ NKT cells from the DN4 thymic population. (A) In vitro generation of aGC/CD1d dimer
+
NKT cells. Thymic DN4 fractions from B6 or CD1dKO mice were co-cultured with OP9/Dll-1 for 8 to 10 days as described in Materials and Methods. The
numbers are the percentages of aGC/CD1d dimer
+ NKT cells within the PI
2 CD45
+ viable lymphocyte gate. Representative data from three
independent experiments for each group of mice are shown. (B) Mixed co-culture of CD1dKO DN4 with WT DN4 fractions. Thymic DN4 fractions from
B6.CD45.1 and CD1dKO (CD45.2
+) mice were mixed at a ratio of 7:3, and cultured for 8 days on OP9/Dll-1. Values indicate the percentage of aGC/
CD1d dimer
+ NKT cells within CD45.2
+ or CD45.2
2 gated viable lymphocytes. APC-conjugated aGC/CD1d dimer and anti-APC microbeads were used
to enrich NKT cells by MACS. Representative data from three independent experiments are shown.
doi:10.1371/journal.pone.0003688.g002
Thymic NKT Cell Precursor
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Mice
B6 mice were purchased from CLEA Japan, CD1dKO mice
with B6 genetic background were from L. Van Kaer (Vanderbilt
University, Nashville, TN) and B6.CD45.1 mice were from The
Jackson Laboratory. Mice were maintained under specific
pathogen-free conditions in the animal facility of the RIKEN
Research Center for Allergy and Immunology and were used at 5–
8 weeks of age unless otherwise indicated. All experiments were in
accordance with protocols approved by the RIKEN Animal Care
and Use Committee.
Flow cytometry and cell sorting
mAbs specific for B220 (RA3-6B2), CD3e (145-2C11), CD4
(RM4-5) (GK1.5), CD8a (53-6.7), CD11b (M1/70), CD11c (HL3)
CD19 (1D3), CD24 (M1/69), CD25 (PC61), CD44 (IM7), CD45
(30-F11), CD45.2 (104), CD62L (MEL-14), CD69 (H1.2F3),
CD122 (TM-b1), Gr-1 (RB6-8C5), NK1.1 (PK136), TCRb
(H57-597), TCRcd (GL3), TER-119 and isotype controls were
purchased from BD Biosciences or eBioscience, and used as FITC,
PE, PerCP-Cy5.5, PE-Cy7, APC, APC-Cy7, or Pacific Blue
conjugates. aGalCer- or vehicle-loaded soluble dimeric mouse
CD1d:Ig fusion protein (BD Biosciences) was used together with
APC-anti-mouse IgG1 (X56; BD Biosciences) mAb to stain NKT
cells. Cell preparation and staining were performed as described
[28]. Propidium iodide (PI) (Sigma-Aldrich) was added to the cell
suspension immediately before analysis to gate out dead cells
where indicated. Flow cytometry was done on a FACS Calibur or
FACS Aria (BD Biosciences). Data were analyzed with FlowJo
(Tree Star).
DN thymocytes were enriched from total thymocytes by
depletion of CD4
+, CD8
+ thymocytes using anti-mouse CD4
and CD8 microbeads and MACS LS columns according to the
Figure 3. Cell surface phenotype and cytokine production of in vitro generated NKT cells. (A) FACS profiles of in vitro generated NKT cells.
The expression of NK1.1, CD4, CD8 and CD44 antigens by NKT cells generated in vitro from B6 DN4 thymocytes on day 10 of culture are compared to
those of ex vivo B6 thymic NKT cells. Viable aGC/CD1d dimer
+ NKT cells were gated for the analysis. Representative data from three independent
experiments are shown. (B) Cytokine secretion profiles of in vitro generated NKT cells. aGC/CD1d dimer
+ NKT cells generated in vitro from B6 DN4
thymocytes cultured on OP9/Dll-1 were FACS sorted on day 10 of culture, as shown in Figure 2A, and co-cultured with aGalCer-pulsed GM-DCs from
either B6 or CD1dKO mice. APC-conjugated aGC/CD1d dimer and anti-APC microbeads were used to enrich NKT cells by MACS. The supernatants
were collected after 48 hours of culture and were assayed for IL-4 and IFN-c levels using the CBA method. Freshly sorted B6 thymic NKT cells served
as positive controls. Values are expressed as mean6SD from three independent experiments. ND, not detected.
doi:10.1371/journal.pone.0003688.g003
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CD1d dimer and anti-APC microbeads were used to enrich NKT
cells by MACS where indicated. Cells were sorted using FACS
Aria. Sorted cells were generally "99% pure as determined by
post-sort analysis using FACS.
OP9/Dll-1 co-cultures
OP9/Dll-1 cells were generated by H. Kawamoto and were
maintained as described [23]. Sorted DN4 thymocytes (6610
5)
were plated onto a 10 cm tissue culture plate (BD Falcon)
containing a monolayer of OP9/Dll-1 cells seeded at 3.5610
5
cells/dish on the previous day. Co-cultures were done in the
presence of 5 ng/ml of each IL-2, IL-7 (R&D Systems) and IL-15
(Peprotech). Cells were transferred onto a fresh monolayer on day
5 of culture and analyzed at the indicated time points.
RT-PCR
Total RNA was prepared from sorted thymocyte populations
(5610
5) using the RNeasy kit (Qiagen) and treated with DNase
(Qiagen). cDNA was synthesized with SuperScript III reverse
transcriptase, oligo(dT) and RNaseOut followed by treatment with
RNase H (Invitrogen). The list of primer pairs used in RT-PCR is
shown in Table S1. The numbers of PCR cycles were as follows:
26 for Ptcra; 28 for Tcrb-C; 29 for Hprt and Rag-1; 30 for Rag-2;3 2
for Rorgt; 39 for Va14-Ja18. The amplified products were stained
with SYBR Safe DNA gel stain (Molecular Probes) and visualized
using a LAS-1000 lumino image analyzer (Fuji Film, Japan). The
identity of RT-PCR generated Va14-Ja18 bands was confirmed
by direct sequencing using an ABI 3100xl genetic analyzer.
Cytokine measurement
GM-DC were prepared from B6 and CD1dKO mice and
pulsed overnight with 100 ng/ml of aGalCer. NKT cells (2610
4)
from either B6 thymus or in vitro DN4 culture origin were plated
with an equal number of GM-DC in 96-well U-bottom plates (BD
Falcon) in a 0.1 ml volume. Culture supernatants were harvested
after 48 hours of culture and assayed for IL-4 and IFN-c levels
with cytokine beads array (CBA) Flex Set (BD Bioscience) using a
Figure 4. Generation of aGC/CD1d dimer
+ NKT cells in vivo by intrathymic injection of CD1dKO DN4 thymocytes. (A) Detection of aGC/
CD1d dimer
+ NKT cells in the thymus. FACS sorted DN4 thymocytes (6610
5) from CD1dKO mice were injected intrathymically into B6.CD45.1
congenic mice, and recipient mice were analyzed 3 weeks later by FACS. Numbers on FACS plots indicate the percentage of cells in the indicated
gates. Anti-CD45.2 staining was used to distinguish between cells of donor and recipient origin. APC-conjugated aGC/CD1d dimer and anti-APC
microbeads were used to enrich NKT cells by MACS. (B) FACS profiles of aGC/CD1d dimer
+ NKT cells generated by intrathymic injection of CD1dKO
DN4 thymocytes. Histogram plots show the expression of NK1.1, CD4 and CD44 by in vivo generated NKT cells from CD45.2
+ CD1dKO DN4
thymocytes compared with resident NKT cells of CD45.2
2 B6.CD45.1 host mice. Staining controls are shown in gray. The data is representative of two
independent experiments.
doi:10.1371/journal.pone.0003688.g004
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Array software (Soft Flow).
Intrathymic injection
B6.CD45.1 recipient mice received a slight whole body c-
irradiation (3 Gy) from a cesium source (Gammacell 40). Mice
were injected intrathymically with FACS sorted DN4 thymocytes
(6610
5)i na1 0ml volume using a Hamilton syringe fitted with a
33G needle. Recipient mice were analyzed 3 weeks after injection.
Supporting Information
Figure S1 Cell surface phenotypes of DN4 thymocytes.
Histogram plots show the expression of CD24, CD62L, CD69
and CD122 antigens by DN4 thymocytes gated as shown in
Figure 1A from B6 (black) and CD1dKO (blue) mice compared to
those of B6 thymic aGC/CD1d dimer
+ NKT cells (red). 7-color
FACS analysis was performed using a FACS Aria. Staining
controls are shown in gray. Representative data of three
independent experiments are shown.
Found at: doi:10.1371/journal.pone.0003688.s001 (1.35 MB TIF)
Figure S2 Post-sort purity of FACS sorted DN4 thymocytes.
Post-sort analysis of FACS sorted DN4 thymocytes from B6 and
CD1dKO mice. Numbers are the percentage of cells in the
indicated quadrants. Representative data from more than six
independent experiments are shown.
Found at: doi:10.1371/journal.pone.0003688.s002 (0.46 MB TIF)
Table S1 Oligonucleotide sequences for primer pairs used in
PCR amplifications.
Found at: doi:10.1371/journal.pone.0003688.s003 (0.04 MB
DOC)
Acknowledgments
We would like to thank H. Kawamoto (RIKEN, RCAI) for OP9/Dll-1
cells. We also would like to thank L. Van Kaer (Vanderbilt University,
Nashville, TN) for providing with CD1dKO mice. We are grateful to Y.
Nagata, N. Hongo, E. Sekine, S. Inoue and A. Terashima for technical
support, and to N. Takeuchi for secretarial assistance.
Author Contributions
Conceived and designed the experiments: ND HW MT. Performed the
experiments: ND SS. Analyzed the data: ND MT. Wrote the paper: ND
MT.
References
1. Godfrey DI, Zlotnik A (1993) Control points in early T-cell development.
Immunol Today 14: 547–553.
2. von Boehmer H (2004) Selection of the T-cell repertoire: receptor-controlled
checkpoints in T-cell development. Adv Immunol 84: 201–238.
3. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H (2003) The
regulatory role of Valpha14 NKT cells in innate and acquired immune response.
Annu Rev Immunol 21: 483–513.
4. Brigl M, Brenner MB (2004) CD1: antigen presentation and T cell function.
Annu Rev Immunol 22: 817–890.
5. Taniguchi M, Seino K, Nakayama T (2003) The NKT cell system: bridging
innate and acquired immunity. Nat Immunol 4: 1164–1165.
6. Bendelac A, Savage PB, Teyton L (2007) The Biology of NKT Cells. Annu Rev
Immunol 25: 297–336.
7. Gapin L, Matsuda JL, Surh CD, Kronenberg M (2001) NKT cells derive from
double-positive thymocytes that are positively selected by CD1d. Nat Immunol
2: 971–978.
8. Egawa T, Eberl G, Taniuchi I, Benlagha K, Geissmann F, et al. (2005) Genetic
evidence supporting selection of the Valpha14i NKT cell lineage from double-
positive thymocyte precursors. Immunity 22: 705–716.
9. Bendelac A (1995) Positive selection of mouse NK1+ T cells by CD1-expressing
cortical thymocytes. J Exp Med 182: 2091–2096.
10. Bezbradica JS, Hill T, Stanic AK, Van Kaer L, Joyce S (2005) Commitment
toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic
ontogeny. Proc Natl Acad Sci U S A 102: 5114–5119.
11. Makino Y, Kanno R, Koseki H, Taniguchi M (1996) Development of
Valpha14+ NK T cells in the early stages of embryogenesis. Proc Natl Acad
Sci U S A 93: 6516–6520.
12. Sato H, Nakayama T, Tanaka Y, Yamashita M, Shibata Y, et al. (1999)
Induction of differentiation of pre-NKT cells to mature Valpha 14 NKT cells by
granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A
96: 7439–7444.
13. Bezbradica JS, Gordy LE, Stanic AK, Dragovic S, Hill T, et al. (2006)
Granulocyte-macrophage colony-stimulating factor regulates effector differenti-
ation of invariant natural killer T cells during thymic ontogeny. Immunity 25:
487–497.
14. Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, et al. (2000)
Tracking the response of natural killer T cells to a glycolipid antigen using CD1d
tetramers. J Exp Med 192: 741–754.
15. Chen YH, Chiu NM, Mandal M, Wang N, Wang CR (1997) Impaired NK1+ T
cell development and early IL-4 production in CD1-deficient mice. Immunity 6:
459–467.
16. Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, et al. (1997) CD1d1
mutant mice are deficient in natural T cells that promptly produce IL-4.
Immunity 6: 469–477.
17. Smiley ST, Kaplan MH, Grusby MJ (1997) Immunoglobulin E production in
the absence of interleukin-4-secreting CD1-dependent cells. Science 275:
977–979.
18. Aifantis I, Bassing CH, Garbe AI, Sawai K, Alt FW, et al. (2006) The E delta
enhancer controls the generation of CD4- CD8- alphabeta TCR-expressing T
cells that can give rise to different lineages of alphabeta T cells. J Exp Med 203:
1543–1550.
19. Benlagha K, Wei DG, Veiga J, Teyton L, Bendelac A (2005) Characterization of
the early stages of thymic NKT cell development. J Exp Med 202: 485–492.
20. Villey I, de Chasseval R, de Villartay JP (1999) RORgammaT, a thymus-specific
isoform of the orphan nuclear receptor RORgamma/TOR, is up-regulated by
signaling through the pre-T cell receptor and binds to the TEA promoter.
Eur J Immunol 29: 4072–4080.
21. He YW, Deftos ML, Ojala EW, Bevan MJ (1998) RORgamma t, a novel
isoform of an orphan receptor, negatively regulates Fas ligand expression and
IL-2 production in T cells. Immunity 9: 797–806.
22. Godfrey DI, Berzins SP (2007) Control points in NKT-cell development. Nat
Rev Immunol 7: 505–518.
23. Schmitt TM, Zuniga-Pflucker JC (2002) Induction of T cell development from
hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17: 749–756.
24. Ciofani M, Zuniga-Pflucker JC (2005) Notch promotes survival of pre-T cells at
the beta-selection checkpoint by regulating cellular metabolism. Nat Immunol 6:
881–888.
25. Matsuda JL, Gapin L, Sidobre S, Kieper WC, Tan JT, et al. (2002) Homeostasis
of V alpha 14i NKT cells. Nat Immunol 3: 966–974.
26. Nakagawa K, Iwabuchi K, Ogasawara K, Ato M, Kajiwara M, et al. (1997)
Generation of NK1.1+ T cell antigen receptor alpha/beta+ thymocytes
associated with intact thymic structure. Proc Natl Acad Sci U S A 94:
2472–2477.
27. Lee PT, Benlagha K, Teyton L, Bendelac A (2002) Distinct functional lineages
of human V(alpha)24 natural killer T cells. J Exp Med 195: 637–641.
28. Watarai H, Nakagawa R, Omori-Miyake M, Dashtsoodol N, Taniguchi M
(2008) Methods for detection, isolation and culture of mouse and human
invariant NKT cells. Nat Protoc 3: 70–78.
Thymic NKT Cell Precursor
PLoS ONE | www.plosone.org 7 November 2008 | Volume 3 | Issue 11 | e3688